Clinically integrated multi-organ point-of-care ultrasound for undifferentiated respiratory difficulty, chest pain, or shock: A critical analytic review

by Ha, Y.-R, Toh, H.-C
Published 2020

The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: Study protocol for a randomized controlled trial

by Ali, R, Toh, H.-C, Chia, W.-K
Published 2020

Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression

by Zeng, J., Shahbazi, M., Wu, C., Toh, H.C., Wang, S.
Published 2014

Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy

by Ang, W.X, Zhao, Y, Kwang, T, Wu, C, Chen, C, Toh, H.C, Mahendran, R, Esuvaranathan, K, Wang, S
Published 2020

Risk communication in clinical trials: A cognitive experiment and a survey

by Cheung, Y.B., Wee, H.L., Thumboo, J., Goh, C., Pietrobon, R., Toh, H.C., Yong, Y.F., Tan, S.B.
Published 2014

SEARCH 8Es: A novel point of care ultrasound protocol for patients with chest pain, dyspnea or symptomatic hypotension in the emergency department

by Ahn J.H., Jeon J., Toh H.-C., Noble V.E., Kim J.S., Kim Y.S., Do H.H., Ha Y.R.
Published 2019

G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo

by Toh, H.C., Sun, L., Soe, Y., Wu, Y., Phoon, Y.P., Chia, W.K., Wu, J., Wong, K.Y., Tan, P.
Published 2014

Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis

by Ho, I.A.W., Toh, H.C., Ng, W.H., Teo, Y.L., Guo, C.M., Hui, K.M., Lam, P.Y.P.
Published 2014

Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer

by Farid, M., Chowbay, B., Chen, X., Tan, S.H., Ramasamy, S., Koo, W.H., Toh, H.C., Choo, S.P., Ong, S.Y.K.
Published 2016

A phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

by Choo, S. P., Chowbay, B., Ng, Q. S., Thng, C. H., Lim, Cindy., Hartono, Septian., Koh, T. S., Huynh, H., Poon, D., Ang, M. K., Chang, S., Toh, H. C.
Published 2013

Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis

by Ang W.X., Li Z., Chi Z., Du S.-H., Chen C., Tay J.C.K., Toh H.C., Connolly J.E., Xu X.H., Wang S.
Published 2020

MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms

by Wang, Y., Toh, H.C., Chow, P., Chung, A.Y.F., Meyers, D.J., Cole, P.A., Ooi, L.L.P.J., Lee, C.G.L.
Published 2014

Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection

by Yaligar, J, Teoh, W.W, Othman, R, Verma, S.K, Phang, B.H, Lee, S.S, Wang, W.W, Toh, H.C, Gopalan, V, Sabapathy, K, Velan, S.S
Published 2020

Electroporation of NKG2D RNA CAR Improves V?9V?2 T Cell Responses against Human Solid Tumor Xenografts

by Ang, W.X., Ng, Y.Y., Xiao, L., Chen, C., Li, Z., Chi, Z., Tay, J.C.-K., Tan, W.K., Zeng, J., Toh, H.C., Wang, S.
Published 2021

MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient Survival

by Wang, Y., Ren, J., Gao, Y., Ma, J.Z.I., Toh, H.C., Chow, P., Chung, A.Y.F., Ooi, L.L.P.J., Lee, C.G.L.
Published 2014

Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis

by Mah W.-C., Thurnherr T., Chow P.K.H., Chung A.Y.F., Ooi L.L.P.J., Toh H.C., Teh B.T., Saunthararajah Y., Lee C.G.L.
Published 2018

Erratum: Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis (PLoS ONE (2014) 9:8 (e104158) (DOI:10.1371/journal.pone.0104158))

by Mah W.-C., Thurnherr T., Chow P.K.H., Chung A.Y.F., Ooi L.L.P.J., Toh H.C., Teh B.T., Saunthararajah Y., Lee C.G.L.
Published 2018

Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients

by Soon S.S., Chia W.-K., Chan M.-L.S., Ho G.F., Jian X., Deng Y.H., Tan C.-S., Sharma A., Segelov E., Mehta S., Ali R., Toh H.-C., Wee H.-L.
Published 2018

Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue

by Novotny-Diermayr, V., Sausgruber, N., Loh, Y.K., Pasha, M.K., Jayaraman, R., Hentze, H., Yong, W.-P., Goh, B.-C., Toh, H.-C., Ethirajulu, K., Zhu, J., Wood, J.M.
Published 2014

Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma

by Wang, W.-W., Ang, S.F., Kumar, R., Heah, C., Utama, A., Tania, N.P., Li, H., Tan, S.H., Poo, D., Choo, S.P., Chow, W.C., Tan, C.K., Toh, H.C.
Published 2014